S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

OTCMKTS:XCURExicure Stock Price, Forecast & News

$2.35
+0.10 (+4.44 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.21
Now: $2.35
$2.36
50-Day Range
$2.25
MA: $2.70
$3.15
52-Week Range
$0.96
Now: $2.35
$3.84
Volume122,668 shs
Average Volume351,977 shs
Market Capitalization$204.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:XCUR
CUSIPN/A
Phone(847) 673-1700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees27
Market Cap$204.80 million
Next Earnings DateN/A
OptionableNot Optionable

Receive XCUR News and Ratings via Email

Sign-up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter.

Exicure (OTCMKTS:XCUR) Frequently Asked Questions

How has Exicure's stock been impacted by COVID-19 (Coronavirus)?

Exicure's stock was trading at $1.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, XCUR stock has increased by 41.6% and is now trading at $2.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exicure?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exicure in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exicure.

How were Exicure's earnings last quarter?

Exicure Inc (OTCMKTS:XCUR) released its quarterly earnings results on Thursday, May, 14th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.09) by $0.10. The company had revenue of $9.18 million for the quarter, compared to analyst estimates of $0.40 million. View Exicure's earnings history.

What price target have analysts set for XCUR?

4 Wall Street analysts have issued 1 year target prices for Exicure's shares. Their forecasts range from $5.00 to $18.00. On average, they expect Exicure's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 325.5% from the stock's current price. View analysts' price targets for Exicure.

Has Exicure been receiving favorable news coverage?

Headlines about XCUR stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Exicure earned a coverage optimism score of -1.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Exicure.

Who are some of Exicure's key competitors?

What other stocks do shareholders of Exicure own?

Who are Exicure's key executives?

Exicure's management team includes the following people:
  • David A. Giljohann, Chief Executive Officer & Director
  • Matthias Schroff, Chief Operating Officer
  • David S. Snyder, Chief Financial Officer
  • Jocelyn Trokenheim, Vice President & Head-Business Developemnt

What is Exicure's stock symbol?

Exicure trades on the OTCMKTS under the ticker symbol "XCUR."

How do I buy shares of Exicure?

Shares of XCUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exicure's stock price today?

One share of XCUR stock can currently be purchased for approximately $2.35.

How big of a company is Exicure?

Exicure has a market capitalization of $204.80 million. Exicure employs 27 workers across the globe.

What is Exicure's official website?

The official website for Exicure is www.exicuretx.com.

How can I contact Exicure?

The company can be reached via phone at (847) 673-1700.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.